The Avenues Study: Dual Use Cessation
Recruiting
Phase 4
Interventional Study
Smoking Cessation
Electronic Cigarette Use
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 21 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 500 (estimated)
- Sponsor
- University of Wisconsin, Madison · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overarching goal of this research is to determine the most effective approach for helping dual users of cigarettes and electronic nicotine delivery systems (ENDS) quit smoking. 500 participants will be enrolled and can expect to be on study for 12 months.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Able to read and communicate in English
* Willing to set a quit date to quit smoking cigarettes in the next 30 days
* Willing and medically able to use varenicline and nicotine patches
* Smoking ≥ 5 cigarettes per day for the past 6 months
* Vaping weekly for at least 6 months…
Contacts